The Source

The Source Blog

Source Shorts: White House Releases Report on Drug Pricing

On Friday, February 9, 2018, the White House released a report from the Council of Economic Advisers (CEA) entitled “Reforming Biopharmaceutical Pricing at Home and Abroad”. The report identifies tw

Continue Reading

Download as PDF

Litigation and Enforcement Highlights – February 2018

In this edition of the Source Litigation and Enforcement Highlights, we review 1) an action against Allergan’s anticompetitive practice concerning its dry eye treatment Restasis, 2) the final conclusion to a highly contested West Virginia hospital merger, 3) an antitrust suit between Marion Health

Continue Reading

Download as PDF

The Source Roundup: February 2018 Edition

 

Happy February! In this edition of the Source Roundup, we cover five academic articles from December and January. The topics this month include: (1) oncologists’ bias against biosimilars, (2) effects of recent mergers and acquisitions on the health system, (3) initial results from Maryla

Continue Reading

Download as PDF

How the Expansion of Association Health Plans Undermines the Safeguards of the ACA

On October 12, 2017, President Donald Trump issued an executive order entitled “Promoting Healthcare Choice and Competition Across the United Sta

Continue Reading

Download as PDF

Do Drugs That Treat the Same Indication Compete with Each Other?

 

High drug prices and the rate at which they are increasing worry most Americans. A quarter of Americans report difficulties affording their medications. Recognizing the need to

Continue Reading

Download as PDF

California Legislative Beat: Newly Introduced Health Bills Seek to Keep Costs Down for Consumers

 

This January, the California Legislature began the second year of its two-year legislative cycle. Back in October, we reviewed three pending healthcare bills in the

Continue Reading

Download as PDF